E-7820 | Interleukin Related interleukin-related.com

Product Name :
E-7820

Search keywords :
E7820

drugId :
null

Target Vo:
Integrin alpha-2

Target Vo Short Name :
ITGA2

Moa_Name:
Integrin alpha-2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Eisai Inc

Active Indication_Name:
Myelodysplastic Syndromes

In Active Indication_Name:
Colonic Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MMP9 Antibody (YA285)
VCAM1 Antibody
Cortactin Antibody: Cortactin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to Cortactin. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts